Advancements in CRISPR-Cas-based strategies for combating antimicrobial resistance
Microbiological Research · 2025-09 · 298 · 128232
DOI: 10.1016/j.micres.2025.128232 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microbiological Research, 2025-09. Verfasst von Ruiting Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, China. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Bacteria, Anti-Bacterial Agents, Drug Resistance, Multiple, Bacterial. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 171 Literaturangaben. Gefördert von: Key Research and Development Program of Zhejiang Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Multidrug resistance (MDR) in bacteria presents a significant global health threat, driven by the widespread dissemination of antibiotic-resistant genes (ARGs). The CRISPR-Cas system, known for its precision and adaptability, holds promise as a tool to combat antimicrobial resistance (AMR). Although previous studies have explored the use of CRISPR-Cas to target bacterial genomes or plasmids harboring resistance genes, the application of CRISPR-Cas-based antimicrobial therapies is still in its early stages. Challenges such as low efficiency and difficulties in delivering CRISPR to bacterial cells remain. This review provides an overview of the CRISPR-Cas system, highlights recent advancements in CRISPR-Cas-based antimicrobials and delivery strategies for combating AMR. The review also discusses potential challenges for the future development of CRISPR-Cas-based antimicrobials. Addressing these challenges would enable CRISPR therapies to become a practical solution for treating AMR infections in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, China.
- College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, China. Electronic address: sundch@zjut.edu.cn.
Förderung
- Key Research and Development Program of Zhejiang Province
- National Natural Science Foundation of China
Zitieren
APA
Zhang, R., Zhou, Q., Huang, S., Zhang, N., & Sun, D. (2025). Advancements in CRISPR-Cas-based strategies for combating antimicrobial resistance. Microbiological Research, 298, 128232. https://doi.org/10.1016/j.micres.2025.128232
Vancouver
Zhang R, Zhou Q, Huang S, Zhang N, Sun D. Advancements in CRISPR-Cas-based strategies for combating antimicrobial resistance. Microbiological Research. 2025;298:128232. doi:10.1016/j.micres.2025.128232
BibTeX
@article{Zhang2025,
author = {Zhang, Ruiting and Zhou, Qi and Huang, Siying and Zhang, Nan and Sun, Dongchang},
title = {Advancements in CRISPR-Cas-based strategies for combating antimicrobial resistance},
journal = {Microbiological Research},
year = {2025},
volume = {298},
pages = {128232},
doi = {10.1016/j.micres.2025.128232}
}
EUVIMED